Autoimmune induced hair loss
Autoimmune induced hair loss
Arash Mostaghimi, M.D., M.P.A., M.P.H., F.A.A.D.
Vice Chair of Clinical Trials and Innovation, Director of the Dermatology Inpatient Service at Brigham & Women’s Hospital
Associate Professor of Dermatology, Harvard Medical School
Amy McMichael, M.D., F.A.A.D.
Professor and Past Chair of Dermatology, Wake Forest School of Medicine
Dr. Amy McMichael is a Philadelphia native who received her medical degree from the University of Pennsylvania School of Medicine. She completed Dermatology residency training at the University of Michigan School of Medicine.
Dr. McMichael is a Professor in the Department of Dermatology at Wake Forest School of Medicine in Winston-Salem, NC. She has held leadership positions in the Department for over 20 years first as Residency Program Director for 12 years and Chair of the Department for 11 years. She has been a leader in her field, including her roles as past President of Skin of Color Society and past President of the National Medical Association Dermatology Section. She recently served as a Board member of the American Academy of Dermatology.
Dr. McMichael’s clinical and research interests include: hair and scalp disorders, psoriasis, and skin of color. She is co-editor of several medical
Mathew Avram, M.D., J.D., F.A.A.D.
Director of the Dermatology Laser & Cosmetic Center, Massachusetts General Hospital
Associate Professor of Dermatology, Harvard Medical School
Director of Dermatology and Minimally Invasive Aesthetics at Aesthetx
Qing Yu Christina Weng, MD
Chief Medical Officer
Chief Medical Officer
Dr. Weng is the CMO of Pelage. She is a physician-scientist and entrepreneur, board-certified dermatologist, and Lecturer at Harvard Medical School. She is experienced in corporate startup strategy as Head of Business Development & Strategy at Kira Pharma and CSO and cofounder of Mymiel Skincare. She is on the Board of Directors for the Dermatology Innovation Forum and Dermatology Summit. Dr. Weng has an undergraduate degree from the California Institute of Technology, MD from Harvard, and she completed dermatology residency and fellowship at Harvard.
Daniel Gil, PhD
Chief Executive Officer
Chief Executive Officer
Dr. Gil is the CEO of Pelage. He is also a Venture Partner with Visionary Ventures. Until 2018, Dr. Gil was a Vice President at Allergan, overseeing the research portfolio and early clinical development. His research contributed to development of 5 marketed drugs and he led 8 clinical development projects. He is an inventor on 70+ issued US patents and author on 45 peer-reviewed research articles. Dr. Gil has an undergraduate degree in Biology from Harvard University and a PhD in Pharmacology from the University of Pennsylvania.
Michael Jung, PHD
Co-Founder
Co-Founder
Professor, UCLA Chemistry & Biochemistry
Dr. Jung is a renowned Medicinal Chemist and co-founder of several successful startups. He is also co-inventor of two FDA approved drugs for prostate cancer (Xtandi & Erleada) with several drugs currently in clinical trials.
Heather Christofk , PhD
Co-Founder
Co-Founder
Professor, UCLA Biological Chemistry
Dr. Christofk is a leader in the metabolism field with a research focus on how metabolism regulates cell state transitions. Her groundbreaking collaborative research with Dr. Lowry revealed that changes in metabolism can instruct hair follicle stem cell activation, forming the basis for the Pelage’s approach to treat hair loss. She is a Professor of Biological Chemistry at the David Geffen School of Medicine at UCLA and Associate Director of Basic and Translational Research at the UCLA Jonsson Comprehensive Cancer Center. She earned her bachelor’s degree from UCLA, her PhD from Harvard, and conducted postdoctoral research at UCSF before joining the faculty at UCLA in 2008.
William Lowry, PhD
President & Co-Founder
President & Co-Founder
Professor, UCLA Molecular, Cell and Dev. Biology
Dr. Lowry is a leader in the stem cell field with 20+ years of research experience resulting in the discovery that hair follicle stem cells can be activated by metabolic manipulation. His work has led to the creation of several startups including Pelage and Sardona, as well as other efforts under development.